During the past decade, Hospital San Bernardo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital San Bernardo" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "CymaBay Therapeutics, Inc." with 1 trials sponsored, "Fundacion Clinica Valle del Lili" with 1 trials sponsored, "HealthCore-NERI" with 1 trials sponsored and "Helse Stavanger HF" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital San Bernardo" #1 collaborator was "Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Ministry of Public Health, Argentina" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Sociedad Interamericana de Cardiología (SIAC)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital San Bernardo" are "Cardiovascular Diseases" (2 trials), "Chest Pain" (1 trials), "Coronary Artery Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Diabetic Nephropathies" (1 trials). Many other conditions were trialed in "Hospital San Bernardo" in a lesser frequency.

Most popular intervention types in "Hospital San Bernardo" are "Drug" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Actos" (1 trials), "Improvement cycle" (1 trials), "MBX-102" (1 trials) and "Spironolactone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital San Bernardo" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hospital San Bernardo". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital San Bernardo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital San Bernardo, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".